Default: Trends in Pharmacological Sciences

ISSN: 0165-6147

Journal Home

Journal Guideline

Trends in Pharmacological Sciences Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Trends in Pharmacological Sciences is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 234. It has an SJR impact factor of 2,964 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,964.

Trends in Pharmacological Sciences focuses its scope in these topics and keywords: receptor, cancer, gpr, implications, py, culpritthe, ctype, cystic, deacetylases, deorphanized, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

- €

Non OA


Trends in Pharmacological Sciences


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

receptor, cancer, gpr, implications, py, culpritthe, ctype, cystic, deacetylases, deorphanized, developmentis, diseasesregulation, dpyd, ?opioid, egfr, electrophysiology, factorkey, family, g?, gap, capecitabine, adenosine, allostery, analgesiastructural, anticancer, approach, asthma, atpactivated, binding, actions, hyperpolarizing, challenge, challenges, channel, channelsrole, clinical,

Best articles by citations

Mice cured of Alzheimer's disease

View more

Phosphodiesterases: the journey towards therapeutics

View more

Anderson and Coyle reply

View more

QSAR: Hansch analysis and related approaches

View more

The lock-and-key principle

View more

Receptor molecular biology. methods in neurosciences vol. 25

View more

PCR in Neuroscience Edited by G. Sarkar, Academic Press, 1995. £42.00 (xv + 455 pages) ISBN 0 12 619255 3

View more

Receptor state and ligand efficacy

View more


View more

Schizophrenia, the dopamine hypothesis and a2-adrenoceptor antagonists

View more

G-protein-coupled receptor dimers in the lime light

View more

Adenosine, antioxidant enzymes and cytoprotection

View more

The 'septide-sensitive' tachykinin receptor: still an enigma

View more

A magic life of chemistry

View more

Pharmacodynamics and drug development

View more

Nematode genome sequence dramatically extends the nuclear receptor superfamily

View more

Risks in combination therapy of antidepressant drugs

View more

Detection of receptor subtypes in radioligand binding studies Do saturation and homologous competition studies have different discriminatory power?

View more

Butler et al. reply

View more

NMDA receptor redox sites: are they targets for selective neuronal protection?

View more

CCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics

View more

A pharmacological link between epilepsy and anxiety?

View more

Searching for magic bullets

View more

The metabotropic glutamate receptors

View more